Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR
Marketer
Crassula Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR
Tri-Action Diabetic Control (1mg/500mg/0.2mg SR) is an anti-diabetic medication combining three active components for managing type 2 diabetes in adults. It helps regulate blood glucose levels. This medication, taken orally with food at the same time daily, requires a doctor's prescription to determine the appropriate dosage, which may be adjusted based on blood sugar monitoring. Consistent use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medicine is part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and carrying a readily available glucose source (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, swelling (edema), blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Those with a history of heart disease should consult their physician before use. Pregnant or lactating women must seek medical advice prior to taking this medication. Regular blood glucose monitoring, along with blood cell and liver function tests as directed by your doctor, are necessary.
Uses of Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Take it on an empty stomach.
Common Side effects of Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consumption should occur on an empty stomach.
How Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR works:
Gemprime Trio LV, a sustained-release tablet containing 1mg, 500mg, and 0.2mg of three distinct antidiabetic agents, offers a triple-action approach to blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Gemprime Trio LV 1mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Gemprime Trio LV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Gemprime Trio LV 1mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Gemprime Trio LV 1mg/500mg/0.2mg SR tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is not suggested for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Gemprime Trio LV 1mg/500mg/0.2mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a low dose; however, use is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gemprime Trio LV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently